�GTCbio just announced the scheduling of one of the largest industry conferences taking place on October 15-17, 2008 in San Diego, CA. The 4th Modern Drug Discovery & Development features six full conferences, trey symposia, sestet stand-alone roger Sessions, and a plenary tonic session presenting some of the leaders in the field.
Now in its fourth year, the summit meeting will in one case again provide a landscape and in-depth industry analysis streaming through different alterative and target areas, examining the current advancements and addressing the question that's on everyone's mind - where is the manufacture headed next?
The Summit's six private tracks will focus on biological therapeutics, translational practice of medicine, drug pattern & lead discovery, emergent targets & therapeutics, pharmacokinetics & pharmacodynamics, and partnering, licensing & outsourcing. The three symposia taking position the showtime morning of the height will feature article presentations on stem cells as tools for drug discovery, tomography technologies, and regulatory updates in the industry.
Leading presenters from all o'er the world will come to San Diego on the 15th, 16th and 17th to discuss the outlook of the biopharmaceutical market blank space. Presenting organizations include, Pfizer, Merck, Novartis, Eli Lilly, GSK, Aventis, Genentech, Amgen, Biogen Idec, NIH, FDA & many more.
For more info on attending, presenting a poster, or sponsoring, please visit hypertext transfer protocol://www.gtcbio.com.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to help the substitution of biopharmaceutical and biomedical intelligence 'tween industry leadership, academic and government organizations, and the financial community.
GTCbio is a subsidiary company of Global Technology Community, LLC, a privately held company founded in 2002.
http://www.gtcbio.com
More information
